Lords Mark Industries Limited
Incorporated in 1979, Kratos Energy & Infrastructure Ltd provides consultancy in various fields[1]
- Market Cap ₹ 67.0 Cr.
- Current Price ₹ 670
- High / Low ₹ 670 / 338
- Stock P/E
- Book Value ₹ 6,398
- Dividend Yield 0.00 %
- ROCE -22.0 %
- ROE -106 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.10 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -18.9% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Consulting Services
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.48 | 4.06 | 4.80 | 3.59 | 3.34 | 6.03 | 5.51 | 1.92 | 0.93 | 0.11 | 0.00 | 0.00 | 9.48 | |
| 2.33 | 3.96 | 4.60 | 3.52 | 3.45 | 5.04 | 5.99 | 1.44 | 0.93 | 0.27 | 0.50 | 0.93 | 13.00 | |
| Operating Profit | 0.15 | 0.10 | 0.20 | 0.07 | -0.11 | 0.99 | -0.48 | 0.48 | 0.00 | -0.16 | -0.50 | -0.93 | -3.52 |
| OPM % | 6.05% | 2.46% | 4.17% | 1.95% | -3.29% | 16.42% | -8.71% | 25.00% | 0.00% | -145.45% | -37.13% | ||
| 0.01 | 0.01 | -0.12 | 0.29 | 1.09 | 0.23 | 0.54 | 0.01 | 0.08 | 0.01 | 0.00 | -5.77 | -5.04 | |
| Interest | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | 0.02 | 0.20 |
| Depreciation | 0.07 | 0.04 | 0.03 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.15 |
| Profit before tax | 0.06 | 0.07 | 0.05 | 0.36 | 0.98 | 1.21 | 0.04 | 0.47 | 0.07 | -0.16 | -0.95 | -6.73 | -8.91 |
| Tax % | 33.33% | 42.86% | 200.00% | 30.56% | 20.41% | 24.79% | 225.00% | 25.53% | 28.57% | 0.00% | 0.00% | 0.00% | |
| 0.04 | 0.05 | -0.05 | 0.25 | 0.78 | 0.91 | -0.05 | 0.35 | 0.04 | -0.16 | -0.95 | -6.73 | -8.91 | |
| EPS in Rs | 0.40 | 0.50 | -0.50 | 2.50 | 7.80 | 9.10 | -0.50 | 3.50 | 0.40 | -1.60 | -9.50 | -67.30 | -89.10 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -303% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -8% |
| 3 Years: | -19% |
| Last Year: | -106% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 171.64 |
| Reserves | 1.99 | 2.04 | 1.99 | 2.34 | 3.12 | 4.03 | 3.98 | 4.33 | 4.38 | 4.22 | 3.27 | -3.46 | 468.13 |
| 0.56 | 0.39 | 0.26 | 0.38 | 1.96 | 2.23 | 0.23 | 0.00 | 0.00 | 1.20 | 1.20 | 5.53 | 205.20 | |
| 3.60 | 3.23 | 4.25 | 2.23 | 0.03 | 0.25 | 0.27 | 0.48 | 0.07 | 0.02 | 1.01 | 1.51 | 45.91 | |
| Total Liabilities | 7.15 | 6.66 | 7.50 | 5.95 | 6.11 | 7.51 | 5.48 | 5.81 | 5.45 | 6.44 | 6.48 | 4.58 | 890.88 |
| 0.53 | 0.50 | 0.02 | 0.02 | 0.02 | 0.11 | 0.09 | 0.08 | 0.07 | 0.07 | 0.06 | 0.05 | 65.82 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.33 | 0.43 | 1.68 | 1.22 | 1.81 | 2.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 51.86 |
| 6.29 | 5.73 | 5.80 | 4.71 | 4.28 | 4.84 | 5.39 | 5.73 | 5.38 | 6.37 | 6.42 | 4.53 | 773.20 | |
| Total Assets | 7.15 | 6.66 | 7.50 | 5.95 | 6.11 | 7.51 | 5.48 | 5.81 | 5.45 | 6.44 | 6.48 | 4.58 | 890.88 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.22 | 0.06 | 1.10 | 0.33 | -1.55 | 0.78 | -1.66 | 0.74 | -0.38 | -1.31 | 0.01 | -4.34 | |
| 0.00 | -0.11 | -0.92 | -0.06 | -0.17 | -0.93 | 3.44 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | -0.17 | -0.18 | -0.13 | 1.58 | 0.26 | -2.00 | -0.23 | 0.00 | 1.20 | 0.00 | 4.33 | |
| Net Cash Flow | 0.22 | -0.21 | 0.00 | 0.14 | -0.14 | 0.11 | -0.22 | 0.50 | -0.38 | -0.11 | 0.01 | -0.01 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.61 | 44.38 | 0.00 | 19.62 | 0.00 | ||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.61 | 44.38 | 0.00 | 19.62 | 0.00 | ||
| Working Capital Days | -125.10 | -76.42 | -160.45 | -177.92 | -171.57 | -111.38 | 107.98 | 332.68 | 957.63 | 8,129.55 | ||
| ROCE % | 2.74% | 2.01% | 5.09% | 5.74% | 17.35% | 16.04% | -7.06% | 8.92% | 1.31% | -2.71% | -8.58% | -22.01% |
Documents
Announcements
-
Further Update On Implementation Of NCLT Approved Resolution Plan - Partial Compliance By BSE And Completion Of Internal Compliances By The Company
15h - Company completed NCLT resolution-plan steps; BSE partially complied, final listing update awaited (16.12.2025).
-
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
9 Dec - CDSCO license and CE mark for world's first AI-based Class C hemodialysis machines; first in India (09.12.2025).
-
Intimation Under Regulation 30 Of SEBI(LODR)
2 Dec - MD Sachidanand Upadhyay to speak at Dec 2, 2025 Medtech conference at Grand Hyatt, Mumbai; discuss merger initiatives.
-
Announcement Under Reg 30 Of SEBI- LODR Reg
28 Nov - Reverse merger completed; NCLT order 28 Jul 2025; ROC approval 21 Nov; BSE filing 27 Nov; 1.25 share swap.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Acquisition Of 85% Stake In Renalyx Health Systems Private Limited
24 Nov - Acquired 85% of Renalyx Health Systems Pvt Ltd (Bengaluru); AI-enabled hemodialysis R&D; completed August 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
-
Financial Year 2007
from bse
-
Financial Year 2002
from bse
Business Overview:[1]
Company is in the business of consultancy services for power projects and trading of machinery